Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.
[epidermolysis bullosa simplex]
Hereditary
keratin
disorders
of
the
skin
and
its
appendages
comprise
a
large
group
of
clinically
heterogeneous
disfiguring
blistering
and
ichthyotic
diseases
,
primarily
characterized
by
the
loss
of
tissue
integrity
,
blistering
and
hyperkeratosis
in
severely
affected
tissues
.
Pathogenic
mutations
in
keratins
cause
these
afflictions
.
Typically
,
these
mutations
in
concert
with
characteristic
features
have
formed
the
basis
for
improved
disease
diagnosis
,
prognosis
and
most
recently
therapy
development
.
Examples
include
epidermolysis
bullosa
simplex
,
keratinopathic
ichthyosis
,
pachyonychia
congenita
and
several
other
tissue-
specific
hereditary
keratinopathies
.
Understanding
the
molecular
and
genetic
events
underlying
skin
dysfunction
has
initiated
alternative
treatment
approaches
that
may
provide
novel
therapeutic
opportunities
for
affected
patients
.
Animal
and
in
vitro
disease
modelling
studies
have
shed
more
light
on
molecular
pathogenesis
,
further
defining
the
role
of
keratins
in
disease
processes
and
promoting
the
translational
development
of
new
gene
and
pharmacological
therapeutic
strategies
.
Given
that
the
molecular
basis
for
these
monogenic
disorders
is
well
established
,
gene
therapy
and
drug
discovery
targeting
pharmacological
compounds
with
the
ability
to
reinforce
the
compromised
cytoskeleton
may
lead
to
promising
new
therapeutic
strategies
for
treating
hereditary
keratinopathies
.
In
this
review
,
we
will
summarize
and
discuss
recent
advances
in
the
preclinical
and
clinical
modelling
and
development
of
gene
,
natural
product
,
pharmacological
and
protein-based
therapies
for
these
disorders
,
highlighting
the
feasibility
of
new
approaches
for
translational
clinical
therapy
.
Diseases
Validation
Diseases presenting
"initiated alternative treatment approaches that may provide novel"
symptom
epidermolysis bullosa simplex
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom